Registry of the treatment of primary insufficiency of the great saphenous vein with a diameter >/= 12 mm, antero-lateral branches, or great saphenous vein insufficiency below the knee with mechano-chemical endovenous ablation (MOCA) - MOCA-X

Rijnstate Ziekenhuis0 个研究点目标入组 90 人开始时间: 待定最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•1. Symptomatic varicose veins, C3-C5
•2. Ultrasound criteria:
•a. Diameter supragenual great saphenous vein (GSV) >/= 12 mm , not tortuous; or
•b. Insufficient antero-lateral branch <12 mm; or
•c. Insufficient below knee GSV < 12 mm
•3. Signed informed consent
•4. Patient consents to follow-up
•5. Age > 18 year en < 80 year

•1. Patient is not capable to provide informed consent
•2. Pregnancy and lactation
•3. C6 varicose veins
•4. Previous surgery or endovenous ablation at to treated segment
•5. Deep venous vein thrombosis in medical history
•6. Oral anti-coagulant therapy
•7. Contra-indications or allergy for sclerosant
•8. Immobilisation
•9. Coagulant disorders or increaased risk for thrombo-embolic complications: known coagulant disorders such as hemofilia A, hemofilia B, Von Willebrand disease, Glanzmann disease, factor VII-deficiency, idiopathic thrombo-cytopenic purpura, factor V Leiden disease and deep venous thrombosis or lung emboli in medical history
•10. Fontaine III of IV peripheral arterial disease
•11. Severe kidney disease: known GFR < 30 ml/min.
•12. Liver diseases accompanied by changes in coagulation of the blood, anamnistic indications for tendency towards haemorrhage , such as epistaxis and spontanuous hematoma, known liver cirrhosis.

发起方

Rijnstate Ziekenhuis